Agreed. Way over sold in choppy markets off the back of a refusal to provide FY23 guidance in August.
There's no way an integrated chemicals manufacturer with 18% EBITDA margins should be trading at 7x FY23 EBITDA of ~$70mn.
I reckon fair value is closer to ~$3.50 off the back of a 15x multiple on FY23 EBITDA of $70mn. Global peers with inferior margins and business models trade at an average of 12x.
If you're interested, I prepared a long-form analysis way back in early September https://www.bayleycapital.com/dangerous-goods-logistics-a-chance-to-monopolise-a-40b-industry/
Agreed. Way over sold in choppy markets off the back of a...
Add DGL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.0¢ |
Change
-0.005(0.92%) |
Mkt cap ! $153.9M | |||
| Open | High | Low | Value | Volume |
| 54.5¢ | 54.5¢ | 54.0¢ | $16.22K | 29.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 126545 | 54.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.0¢ | 104152 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| DGL (ASX) Chart |